Association of Polypharmacy With Mild Cognitive Impairment and Cognitive Ability

Abstract

Polypharmacy is common in the elderly and is associated with significantly lower cognitive capacity and higher risks of MCI and dementia, especially for persons without diabetes, hypertension, hyperlipidemia, or cerebrovascular diseases.